Fractional flow reserve measurements to identify justified targets for PCI in patients with stable angina: FAME 2 and beyond.
Frits H.A.F. de Man, Clemens von Birgelen
Abstract
Frits H.A.F. de Man, Clemens von Birgelen
Abstract
During the past decades, percutaneous coronary intervention (PCI) has become an important, widely applied therapeutic approach for the treatment of patients with symptomatic coronary artery disease and angiographically significant coronary obstructions. While the indication for PCI in the setting of acute coronary syndromes is established very well (1), there is an ongoing debate about the role of PCI in patients with ischemic heart disease and stable symptoms
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
During the past decades, percutaneous coronary intervention (PCI) has become an important, widely applied therapeutic approach for the treatment of patients with symptomatic coronary artery disease and angiographically significant coronary obstructions. While the indication for PCI in the setting of acute coronary syndromes is established very well (1), there is an ongoing debate about the role of PCI in patients with ischemic heart disease and stable symptoms
Key concepts: Conventional PCI, Fractional flow reserve, Medicine, Percutaneous coronary intervention, Stable angina, Cardiology, Coronary artery disease, Internal medicine